Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 18, 2022
Patent Application Number
16805453
Date Filed
February 28, 2020
Patent Citations
Patent Primary Examiner
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.